Dianthus Therapeutics (DNTH) Operating Leases (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Operating Leases of $1.0 million for Q4 2025, down 12.98% year-over-year from $1.2 million in Q4 2024, and down 4.59% quarter-over-quarter from $1.1 million in Q3 2025.
Dianthus Therapeutics (DNTH) Operating Leases (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- In Q4 2025, Operating Leases fell 12.98% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 12.98% YoY), while the FY2025 annual figure was $1.0 million, down 12.98% from the prior year.
- Operating Leases for Q4 2025 stood at $1.0 million, down from $1.1 million in the prior quarter.
- The five-year high for Operating Leases was $32.4 million in Q1 2022, with the low at $30000.0 in Q2 2024.
- The 4-year median for Operating Leases is $1.1 million (2025), against an average of $7.5 million.
- The sharpest annual moves came in 2023 and 2025: Operating Leases plunged 99.05% in 2023, then soared 3630.0% in 2025.
- Dianthus Therapeutics' Operating Leases stood at $438000.0 in 2022, then plunged by 61.64% to $168000.0 in 2023, then jumped by 597.02% to $1.2 million in 2024, then declined by 12.98% to $1.0 million in 2025.
- Business Quant data shows DNTH's Operating Leases at $1.0 million in Q4 2025, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Dec 31, 2023 | 168,000.00 |
| Sep 30, 2023 | 257,000.00 |
| Dec 31, 2022 | 438,000.00 |
| Sep 30, 2022 | 27.18 Mn |
| Jun 30, 2022 | 31.61 Mn |
| Mar 31, 2022 | 32.35 Mn |